Hollow temples after GLP-1-associated weight loss usually reflect reduced facial fat and changing structural support during significant or rapid weight loss. They are not currently established as a drug-specific injury. Depending on anatomy and weight stability, management may include observation, skin-quality support or conservative volume restoration following medical assessment.
I want to talk about an area of the face that most people rarely think about until it changes: the temples.
Someone may come to see me after losing a significant amount of weight and say their eyes look more tired, their cheekbones feel too prominent or their face suddenly appears older. They often cannot identify exactly what has changed.
When we assess the whole face, part of the answer may be sitting at the sides of it.
Loss of fullness in the temples can change the transition between the forehead, eyes and cheeks. It can make the upper face appear narrower and create shadows that were not visible before. Online, this is increasingly being called “GLP-1 temporal wasting” or “Ozempic temples”.
Those names make the change sound like a new medical condition. It is more accurate to describe it as temple hollowing associated with facial volume loss, which can occur after significant weight loss whether or not medication was involved. For a broader explanation, read How to Avoid Ozempic Face.
Key Takeaways
- Hollow temples may become more noticeable after rapid or substantial weight loss.
- The change is probably related mainly to loss of facial fat and altered support, not a proven toxic effect of GLP-1 medication on the temples.
- Temple hollowing can affect how the eyes, cheeks and upper face are perceived.
- Treatment is not always necessary, particularly while weight is still changing.
- Skin boosters and polynucleotides may support skin quality, but they do not replace substantial structural volume loss.
- Temple filler is not a casual treatment. The area contains important blood vessels and requires advanced anatomical knowledge.
- A full-face assessment is more useful than treating the temples in isolation.
What is temporal hollowing?
Temporal hollowing means a visible reduction in fullness between the outer brow, hairline, and upper cheek.
The medical term “temporal wasting” is also used in other health contexts, sometimes to describe muscle or tissue loss associated with illness. For someone who is otherwise well and has recently lost weight, temple hollowing is generally the clearer and less alarming description.
Common signs include:
- A deeper indentation at the side of the forehead
- More visible bony contours around the outer eye
- A sharper transition between the forehead and cheek
- Increased shadowing around the eyes
- A narrower or more angular upper face
- A face that appears tired or less supported
The change can be subtle. Many people notice the effect before they notice the temples themselves.
Why do the temples matter to facial balance?
The temples sit at a visual junction.
They connect the forehead to the cheek and help create a smooth outer contour around the eyes. When that transition is full and balanced, we rarely look at it directly. When it becomes hollow, the eye begins to catch on the change.
The outer brow may appear more prominent, the eyes can look more shadowed and the cheekbones may seem sharper. The upper face can also look narrower or more angular.
This is why I would never assess temple hollowing as a separate problem.
The question is not simply, “Are the temples hollow?” It is, “How has the relationship between the temples, forehead, eyes, cheeks and lower face changed?”
That distinction is what prevents volume restoration from becoming indiscriminate filling. It is also central to understanding how facial proportions work together.
Do GLP-1 medications directly cause hollow temples?
The honest answer is that we do not yet know whether GLP-1 medicines have a direct, medication-specific effect on facial tissue.
What we know more clearly is that medicines such as semaglutide and tirzepatide can produce substantial weight loss. When the body loses fat, the face may lose it too.
Research into this specific area is still emerging. A radiographic study published in 2025 reported an average reduction in midfacial volume associated with total weight loss, particularly within superficial fat compartments. However, this was not a study of the temples alone.
A broader 2026 clinical review found that GLP-1-associated weight loss may affect facial fat, skin and lean tissue, but also acknowledged that the evidence is limited. The available data do not show that every facial compartment loses volume equally.
Facial hollowing is also well recognised after major weight loss unrelated to GLP-1 medication. It can involve the cheeks, temples, area around the eyes and lower face, as described in research on soft-tissue facial changes following massive weight loss.
This leads to an important distinction:
GLP-1 medicines enable significant weight loss. Facial volume loss may accompany that weight loss, but “Ozempic temples” is not currently a formal diagnosis or an established drug-specific adverse reaction.
Patients should never stop, reduce, or change prescribed medication because of an aesthetic concern without speaking to their prescribing clinician.
Why does weight loss affect some faces more than others?
Two people can lose the same amount of weight and see very different facial changes.
Starting facial anatomy
Someone with naturally lean temples or a narrow upper face may notice hollowing sooner than someone with more baseline fullness.
Amount and rate of weight loss
Larger changes may make facial volume loss more visible. Rapid change can also feel more dramatic because the person has less time to adjust to their new appearance.
Age and skin elasticity
Younger skin may adapt differently from skin that already has reduced collagen and elasticity. This does not mean every younger patient is protected or every mature patient will develop laxity.
Previous aesthetic treatments
Existing filler may change how facial volume loss appears. Some areas may retain support while untreated areas become leaner, potentially creating a new imbalance.
Genetics and fat distribution
Facial fat compartments vary naturally. There is no reliable formula that predicts exactly where an individual will lose volume first.
Will hollow temples improve when weight stabilises?
Sometimes the appearance settles. Sometimes it remains.
Early in a weight-loss journey, facial proportions may continue to change. Treating every new hollow immediately can lead to repeated adjustments and, potentially, unnecessary volume.
Waiting may be sensible when:
- Weight is still changing quickly
- The hollowing has only recently appeared
- The person is not sure whether the change bothers them
- There are nutritional or medical concerns requiring attention
- The face is changing globally rather than in one stable area
Weight stability does not guarantee that lost facial volume will return. It simply gives the practitioner a more reliable facial structure to assess.
The appropriate timing should be decided individually and, where relevant, coordinated with the clinician supervising the patient’s weight-management treatment.
What can you do before considering aesthetic treatment?
The first step is not to purchase a supplement, book filler, or stop medication.
It is to understand what has changed.
- Speak to your prescribing clinician. Discuss the rate of weight loss, appetite, nutrition and any wider symptoms.
- Do not adjust medication independently. Facial hollowing is not a reason to alter a prescribed treatment without medical advice.
- Support general nutrition. A suitably qualified clinician or dietitian can help if reduced appetite makes it difficult to maintain adequate protein or micronutrient intake.
- Use consistent sun protection. It will not replace lost volume, but protecting the skin remains important.
- Allow time for assessment. A change that feels dramatic today may look different once weight and hydration are stable.
- Avoid chasing each hollow separately. The temple may only be one part of a broader change in facial balance.
Creams can support the surface of the skin. They cannot recreate a depleted deep fat compartment. Supplements should not be presented as a proven method of restoring temple volume unless there is good evidence for the specific product and claim.
How I assess temple hollowing after weight loss
My starting point is always the whole face.
I look at:
- The contour from the forehead into the temple
- Brow and orbital support
- The relationship between the temple and lateral cheek
- Midface volume and cheek projection
- Skin quality and laxity
- Lower-face support
- Facial movement
- Previous filler or other treatments
- Whether weight is stable
- The patient’s health, medication history and expectations
Sometimes the temples are contributing significantly to the concern. Sometimes they simply look hollow because volume has changed elsewhere.
That is why adding product directly into the most obvious shadow is not always the best answer.
The goal is not to make the temples look full. It is to restore a proportionate transition without erasing the patient’s natural structure.
Treatment options for hollow temples
There is no single treatment that is right for every patient.
Observation and reassessment
This may be appropriate when facial changes are recent or weight is still stabilising. The limitation is that lost volume may not return.
Hyaluronic acid dermal filler
Dermal fillers may restore structural volume and contour in carefully selected patients. Results are usually visible immediately, but filler is temporary and carries recognised injection risks.
Collagen-stimulating injectables
These may provide gradual tissue support in selected patients. They are not immediately reversible and are not suitable for everyone.
Polynucleotides
Polynucleotide treatments may support aspects of skin quality in appropriately selected areas. They do not replace significant structural temple volume.
Skin boosters and Profhilo
These may support hydration and aspects of skin quality. Profhilo is not a substitute for structural volume restoration.
Fat transfer
Fat transfer uses the patient’s own fat and may provide longer-term structural volume. It is a surgical option, is less predictable than an injectable gel and sits outside routine non-surgical care.
A combination may sometimes be appropriate, but more treatments do not automatically produce a better result.
Can temple filler restore hollow temples?
Hyaluronic acid filler can restore volume in carefully selected patients. It provides an immediate change and can be dissolved with hyaluronidase if clinically necessary.
However, the temple is anatomically complex. It contains branches of the superficial temporal artery and vascular connections that can make poorly placed filler dangerous. Vascular complications are uncommon, but they may cause tissue injury and, in rare cases, visual loss. A clinical review of temple anatomy and injection safety explains why precise anatomical knowledge is essential.
This treatment should only be performed following a proper medical assessment by a practitioner with advanced knowledge of temporal anatomy and complication management.
“Reversible” does not mean risk-free. Readers considering treatment may also find Sculpt Clinic’s guide, Are Dermal Fillers Safe? helpful.
Can polynucleotides treat hollow temples?
Polynucleotides are intended primarily to support aspects of skin quality and tissue regeneration. They do not function like a structural hyaluronic acid filler.
They may be considered when the main concern is thin, crepey or poor-quality skin rather than substantial loss of contour. They should not be presented as a direct replacement for missing temporal volume.
The same distinction applies to skin boosters and Profhilo. Improving hydration or skin quality can be valuable, but it is not the same as restoring structural support.
What about collagen stimulators?
Collagen-stimulating injectables can create gradual improvement in selected patients. They behave differently from hyaluronic acid fillers and are not always readily reversible.
Product choice, injection plane, facial anatomy and the practitioner’s experience all matter. They should not be used simply because “regenerative aesthetics” is trending.
Common myths about GLP-1 temple hollowing
Myth 1: The medication melts fat specifically from the temples
There is currently insufficient evidence to make that claim. Significant weight loss is the more established explanation, although medication-specific mechanisms continue to be studied.
Myth 2: Stopping the medication will restore facial volume
This is not predictable and medication should never be stopped for aesthetic reasons without advice from the prescribing clinician.
Myth 3: A skin booster can replace lost volume
Skin boosters may improve hydration and aspects of skin quality. They do not recreate substantial structural fullness.
Myth 4: Temple filler is a simple treatment
The temple is a higher-risk anatomical area. Practitioner selection, assessment, technique and emergency preparedness are essential.
Myth 5: More filler creates a younger result
Excessive volume can distort the outer face and make the result look heavy. Natural rejuvenation depends on proportion, not quantity.
Myth 6: Every hollow temple needs treatment
Some people have naturally hollow temples. Treatment should be based on the patient’s anatomy, concerns and overall facial balance, not an online trend.
Risks and limitations
Any injectable treatment may cause temporary redness, tenderness, swelling, bruising or asymmetry.
Less common but more significant risks include:
- Infection
- Persistent lumps or nodules
- Delayed inflammatory reactions
- Product migration or irregularity
- Vascular occlusion
- Tissue damage
- Rare visual complications
Treatment cannot guarantee that the face will return to exactly how it looked before weight loss.
Evidence surrounding GLP-1-associated facial changes is developing. Much of the current treatment guidance is based on anatomical principles, evidence from major weight loss and expert clinical experience rather than large, long-term trials designed specifically around GLP-1 users.
That limitation should be discussed honestly.
When might treatment be unsuitable?
Treatment may be postponed or avoided when:
- Weight remains unstable
- Expectations are unrealistic
- The person is seeking treatment because of external pressure
- There is active infection or inflammation
- Medical history makes an injectable unsuitable
- The main concern would not improve through volume restoration
- The risks outweigh the likely benefit
- The patient does not fully understand the limitations
A good consultation can end with a decision not to treat.
The right place to start
Hollow temples can change the way the entire face reads, but they should not be treated as an isolated defect.
If your face looks different after weight loss, the most useful first step is to understand which relationships have changed. The temple, cheek, eye area and lower face may all be contributing to what you see.
At Sculpt Clinic in London, consultations begin with a structured full-face assessment. If treatment is appropriate, the plan is built around your current anatomy, weight stability and natural proportions. If waiting is the better option, we will tell you.
Book a consultation with Dr Zack Ally to discuss facial changes following weight loss.
Frequently Asked Questions
“Ozempic temples” is an informal term for hollowing at the sides of the forehead noticed during or after GLP-1-associated weight loss. It is not a formal diagnosis and can also occur after other forms of significant weight loss or as part of ageing.
Not everyone develops facial changes, and the outcome is not necessarily permanent. Some changes may settle after weight stabilises, while established volume loss may remain. Individual anatomy, age, skin quality and the amount of weight lost all influence the result.
Temple filler carries recognised risks because the area contains important blood vessels. It should only be considered after medical assessment and performed by a practitioner with advanced anatomical training and experience managing complications.
There is no standard amount. The correct quantity depends on anatomy, severity, product characteristics and the relationship between the temples and the rest of the face. Conservative treatment is generally preferable.
Often, but not always. Stable weight can make treatment planning more predictable. The timing should be agreed with the aesthetic practitioner and, where relevant, the clinician supervising the weight-management programme.
No. Polynucleotides may support skin quality, but they do not replace significant structural volume in the same way as an appropriately selected filler.
Do not stop or alter prescribed medication without speaking to your prescribing clinician. An aesthetic concern should be assessed separately from the medical benefits and risks of treatment.
Temporal wasting broadly describes loss of tissue in the temple region. In the context of weight loss, it is often used online to describe visible temple hollowing. It is not a formal diagnosis of a GLP-1-specific injury, and the term can have different meanings in other medical settings.
Yes. Significant weight loss can reduce facial fat and make the temples appear more hollow. The extent varies according to starting anatomy, age, skin quality, genetics and the amount of weight lost.
Look for photographs taken with consistent lighting, facial expression, camera angle and head position. The result should create a smoother transition between the forehead and cheek without making the outer face look heavy. Photographs are examples, not guarantees of an individual outcome.
Ready to Have an Honest Conversation?
Book a Consultation with Dr Zack Ally
At Sculpt Clinic, consultations begin with a full-face assessment, not a quick fix for one area. If you are on a weight loss journey and want a plan for how your face will be supported along the way, we would like to hear from you.
Book Your ConsultationDisclaimer
This article provides general information and does not replace individual medical advice. Do not start, stop or change a GLP-1 medication without consulting your prescribing clinician. Aesthetic treatments should only be considered following an appropriate face-to-face assessment. Individual outcomes and risks vary.